跳至主要内容
临床试验/CTRI/2019/09/021107
CTRI/2019/09/021107尚未招募不适用

An open clinical trial of Siddha external formulations as Pugai and Nasiyam in the treatment of Peenisam (Chronic Rhinosinusitis)

Dr L Nilopher1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2019年9月14日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
20
试验地点
1
主要终点
Primary outcome of the study is to relieve the symptoms and it will be assessed by using the validation of the self-questionnaire for assessing the control of allergic rhinitis

研究概览

简要总结

Therapeutic efficacy of sidindha formulations Pugai and Nasiyam will be assessed by relieving the symptoms in Peenisam (Chronic Rhinosinusitis) and it will be assessed by using the validation of theself-questionnaire for assessing the control of allergic rhinitis

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Not Applicable

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • Running nose Facial pain or pressure or fullness Nasal congestion sneezing/coughing headache that is worse in morning, when bending forward itchy eyes and nose loss of smell.

排除标准

  • Common cold Nasal polyp Tonsillitis Migraine Bronchial asthma Pulmonary tuberculosis syphilis.

结局指标

主要结局

Primary outcome of the study is to relieve the symptoms and it will be assessed by using the validation of the self-questionnaire for assessing the control of allergic rhinitis

时间窗: Primary outcome of the study is to relieve the symptoms and it will be assessed by using the validation of the self-questionnaire for assessing the control of allergic rhinitis

次要结局

未报告次要终点

研究者

发起方
Dr L Nilopher
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验